Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2005 / Cilt: 45 - Sayı: 1

Evaluation of 204 patients with Henoch-Schönlein purpura

Henoch-Schönlein purpuralı 204 olgumuzun değerlendirilmesi

Pages
14–16
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In our case group, renal involvement that is the most fearing and permanent complication of the disease; was found to be lower when compared with the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to evaluate the Henoch-Schönlein purpura cases diagnosed with general clinical course, its therapy and related complications.
📊
Key Findings & Data:Materials and Methods: 204 patients who were observed with the diagnosis of Henoch-Schönlein purpura, were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: In our case group, renal involvement that is the most fearing and permanent complication of the disease; was found to be lower when compared with the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to evaluate the Henoch-Schönlein purpura cases diagnosed with general clinical course, its therapy and related complications. Materials and Methods: 204 patients who were observed with the diagnosis of Henoch-Schönlein purpura, were evaluated retrospectively. Results: The typical skin rash which is very important for diagnosis was absent in 19.2% of the patients at first; but all of them developed the rash during the course. The laboratory studies directed towards the etiology revealed ASO (+) in 45 patient (22.05%), GABHS in 4 (1.96%), Hepatitis B infection in 4 (1.96%), Giardia intestinalis infection in 4 (1.96%), Mycoplasma in 2 (0.98%), EBV IgM in 2 (0.98%), parvovirus IgM in 1 (0.49%), and Entamoeba histolytica trophozoites in the stool of 1 patient (0.49%). There was gastrointestinal tract involvement in 113 (55.39%) of the patients, persistant nefro-pathy developed 10 of them (4.9%). Renal involvement presenting with microscopic hematuria or proteinuria was found in 30 patients (14.7%) with HSP. Conclusion: In our case group, renal involvement that is the most fearing and permanent complication of the disease; was found to be lower when compared with the literature.

Özet

Amaç: Henoch-Schönlein purpuralı (HSP) olguları genel özellikleri, etiyolojisi, klinik seyri, komplikasyonları, tedavisi açısından değerlendirmek. Gereç ve Yöntem: Henoch-Schönlein purpura tanısı ile izlenen 204 olgu retrospektif olarak incelendi. Bulgular: Tanıda çok önemli olan tipik deri döküntüleri hastaların %19.2'sinde başlangıçta yoktu, hastalığın seyri sırasında ise %100'ünde gözlendi. Etiyolojiye yönelik tetkiklerimizde, hastaların 45'inde (%22.05) ASO (+), 4'ünde (%1.96) grup A beta hemolitik streptokok, 4'ünde (%1.96) Hepatit B enfeksiyonu, 4'ünde (%1.96) Giardia intestinalis enfeksiyonu, 2'sinde (%0.98) Mycoplasma, 2'sinde (%0.98) EBV IgM pozitifliği, 1'inde (%0.49) parvovirus IgM pozitifliği, 1'inde (%0.49) dışkıda Entamoeba histolytica trofozoidleri tespit edildi. HSP'Iİ olguların 30'unda (%14.7) mikroskopik hematüri ve/veya proteinüri şeklinde belirti veren böbrek tutulumu vardı. Bunlardan 10 olguda (%4.9) kalıcı nefropati gelişti. Hastaların 113' ünde (%55.39) gastrointestinal sistem tutulumu mevcuttu. Tartışma: Hastalığın en korkulan ve kalıcı komplikasyonu olan renal tutulumun, bizim hasta grubumuzda literatürle karşılaştırıldığında daha düşük olduğunu tespit ettik.

🔖

Cite This Article

USTA, M., DURSUN, F., PELİT, M., ERGÜVEN, M., FEDAKAR, A., ÖZKAN, H., AĞAÇHAN, N., SAÇAR, O. (2022). Evaluation of 204 patients with Henoch-Schönlein purpura. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 45 - Sayı: 1, 14–16. https://ajindex.com/articles/535637

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Bagga A, Dillon MJ. Leukocytoclastic vasculitis. İn: Cassidy JT, Petty RE, editors. Textbook of Pediatric Rheumatology. Philadelphia: WB Saunders Company; 2001:569-79. Athreya BH. Vasculitis in children. Ped Clin N Amer 1995;42:1239-61.
  2. Yalçındağ A, Sundel R. Vasculitis in childhood. Curr Opin Rheumatol 2001; 13:422- 7. Kraft DM, McKee D, Scott C. Henoch-Schönlein purpura: a review. Am Fam Physician 1998;58:405-8. Szer IS. Henoch-Schönlein purpura: when and how to treat? J Rheumatol 1996;23:161-5. Henoch-Schönlein purpura or vasculitis. In: Behrman RE, Kli- egman RM, Arvin AM, edts. Textbook of Pediatrics. 15th ed. WB Saunders Company; 1996:667-8. Avşargil D. Sistemik vaskülitler. In: Klinik Romatoloji E; (II-3):371-83.
  3. Tizand EJ. Henoch-Schönlein purpura, Arch Dis Child 1999;80:380-3.
  4. Sticca M, Baha S, Spollino L et al. Epidemiological analysis of 98 cases. Pediatr Med Chir 1999:9-12.
  5. Kumar L, Singh S, Goraya JS et al. Henoch-Schönlein purpura: the Chandigarh experience. Indian Pediatr 1998;35:19-25.
  6. Lin SJ, Chao HC, Huang JL. Gastrointestinal involvement as the initial manifestation in children with HenochSchönlein purpura- clinical analysis of 27 cases. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1998;39:186-190.
  7. Katz S, Borst M, Seekri I, Grosfeld JL. Surgical evaluation of Henoch-Schönlein purpura. Experience with 110 children. Arch Surg 199;126:849-53.